Developer Strategy

Why projects don't sell: a diagnostic, not a marketing brief

When a project stalls, the first instinct is to change the agency. In our experience the cause is usually further upstream, and spending harder on a broken funnel scales the loss.

Published
Author
The Genesis Advisory Desk
Reading time
11 min

The short answer

Slow sales have four possible root causes: the product is wrong for the segment, the price is wrong for the product, the process is losing buyers who are already interested, or there is genuinely insufficient demand at any price the project can accept. Each has a different remedy, and increasing marketing spend only helps in the fourth case — which is the least common.

The diagnostic sequence

Almost every developer we meet with slow inventory has already increased marketing spend, changed the creative, and often changed the agency. Occasionally that was the right response. Usually it was an expensive way of confirming that the problem was elsewhere.

The reason is that marketing addresses only one of four possible failures — insufficient top-of-funnel demand — and that is the least common of the four. If the product is mispositioned, more visitors see a product that is not for them. If the price is wrong, more visitors negotiate and leave. If the process is leaking, more leads arrive and are lost at the same rate.

The diagnostic therefore has to run in a specific order, from the bottom of the funnel upward, because a leak at a lower stage invalidates any conclusion about a higher one.

SymptomLikely causeWhat actually fixes it
Good footfall, poor bookingsPrice, or product-segment mismatchRe-price the ladder, or reposition to the segment the product fits
Good leads, poor site visitsProcess: response time, qualification, schedulingSLA enforcement, call quality audits, visit confirmation discipline
Good visits, long negotiations, high drop-offPrice, or a specific unresolved objectionIdentify the objection from call recordings; fix or price it
Bookings that cancelSoft closures, or financing failureQualification discipline, loan pre-screening, token policy
Low lead volume at reasonable costGenuine demand shortfall, or channel mixChannel reallocation; if demand is absent, re-price or re-segment
Everything weakPositioningReposition. Spending more does not fix a product aimed at nobody

Start with the site visit conversion rate

The single most diagnostic number in a stalled project is visit-to-booking conversion. A visitor who has travelled to the site has demonstrated real intent; losing them is expensive and informative.

If visit-to-booking conversion is healthy and the problem is volume, the issue is upstream — demand generation or lead handling. If visit-to-booking conversion is poor, no amount of additional footfall will help, and the honest conclusion is that something about the product, the price or the site experience is losing people who arrived wanting to buy.

The fastest way to find out which is to listen to recorded calls and to sit in the sales gallery for a day. Both are unglamorous and both routinely produce the answer within hours — an objection nobody has addressed, a competitor comparison nobody has a response to, a show unit that disappoints, an approach road that sets the wrong expectation.

The uncomfortable possibility: the product is wrong

The hardest diagnosis to deliver is that the configuration mix is wrong for the catchment — that the project was designed for a buyer who does not exist here in sufficient numbers.

It is hard because it is largely irreversible after sanction. Carpet areas, configuration mix and efficiency are fixed. The remaining levers are price, payment structure, release sequence and repositioning to a different segment — a narrower set of options than the developer had at design stage.

It is also the diagnosis most often avoided, because accepting it means accepting that the error was made upstream by the promoter rather than downstream by the sales team. But avoiding it produces years of expensive activity aimed at a problem that is not the problem.

Where this is the conclusion, the honest remedy is usually to re-price into the segment the product actually fits, accept the realisation that segment supports, and protect velocity — rather than to defend an aspirational price into a segment that is not there.

Price is a symptom as often as a cause

Developers frequently frame the problem as price and then reject the remedy, because cutting price is painful and visible. That framing conflates two different situations.

If the product is correctly specified for its segment and simply priced above what that segment has demonstrably paid, the remedy is a price correction and it will work. If the product is specified for a segment that is not present, a price cut moves the project into a different segment's range — which can work, but it is a repositioning rather than a discount, and it needs the narrative, the channel mix and the sales pitch to change with it.

The distinction matters because the second case requires far more than a new price sheet. Cutting price without repositioning produces a cheap version of a product aimed at the wrong buyer, and the market reads it as distress.

What we do first on a stalled mandate

When we are appointed on a project that is already slow, the first two weeks are diagnosis rather than activity, and we resist pressure to launch a campaign in that window.

We instrument the funnel and establish the real conversion rates at each stage. We listen to a sample of recorded calls. We spend time in the gallery observing actual visits. We map the competitive set on the dimensions buyers compare and identify where this project loses. We pull registered transaction data for comparable inventory to establish what the catchment has actually paid. And we ask channel partners in the catchment, directly, why they are not selling it.

That last conversation is frequently the most useful and the least often had. Channel partners know exactly why a project is not moving, they will say so if asked in a way that does not require them to be diplomatic, and their answer is usually specific: the price, a competitor's better carpet, a possession-date credibility problem, or a payout that arrives too slowly to be worth the effort.

This article is general commentary for information only. It is not legal, tax or investment advice, and statutory positions referred to should be confirmed with qualified advisers for your circumstances.

Questions

Frequently asked.

Should we change our marketing agency if sales are slow?

Only if the diagnosis points to demand generation or lead handling as the failure. If visit-to-booking conversion is poor, the problem is product, price or site experience, and changing the agency will not move it — it will simply deliver more visitors to the same loss.

How do we know whether price is the problem?

Compare achieved realisation on registered transactions for genuinely comparable inventory in the catchment against your price ladder. If your ladder sits materially above what comparable product has registered at, and your visit-to-booking conversion is poor, price is at least part of it.

Is it ever too late to fix a stalled project?

It is rarely too late to improve the outcome, but the options narrow with time. After sanction, product cannot change. After a failed relaunch, credibility with channel partners is harder to recover. The most expensive version is a project that has been slow for three years with no diagnosis, because the market has now formed a settled opinion about it.

Should we cut price or wait for the market to improve?

Waiting has a cost that is easy to ignore: finance cost on carried inventory, plus the compounding credibility problem of being the project that never sells. The comparison should be explicit — model the carry cost of waiting against the realisation loss of a price correction. Frequently the correction is cheaper than the wait.

Apply this to your project

Evidence is only useful when it reaches a decision.

Tell us what you are deciding. We will bring the evidence and a stated view.